Trial Outcomes & Findings for Comparative Clinical Evaluation of Daily Disposable Lenses in Symptomatic Daily Disposable Lens Wearers (NCT NCT01035905)
NCT ID: NCT01035905
Last Updated: 2012-07-10
Results Overview
Lens awareness, as interpreted by the subject and reported by the subject in a questionnaire as a single, retrospective evaluation of 4-week's wear time. Frequency of lens awareness was measured on a 4-point scale, with 1 being never and 4 being always. Four-week ratings were compared to baseline ratings, and a negative difference (4 week minus baseline) represented an improvement.
COMPLETED
NA
63 participants
4 weeks of wear
2012-07-10
Participant Flow
Participant milestones
| Measure |
Nelfilcon A
Nelfilcon A contact lens
|
Narafilcon A
Narafilcon A contact lens
|
|---|---|---|
|
Overall Study
STARTED
|
32
|
31
|
|
Overall Study
COMPLETED
|
31
|
30
|
|
Overall Study
NOT COMPLETED
|
1
|
1
|
Reasons for withdrawal
| Measure |
Nelfilcon A
Nelfilcon A contact lens
|
Narafilcon A
Narafilcon A contact lens
|
|---|---|---|
|
Overall Study
Lack of Efficacy
|
1
|
1
|
Baseline Characteristics
Comparative Clinical Evaluation of Daily Disposable Lenses in Symptomatic Daily Disposable Lens Wearers
Baseline characteristics by cohort
| Measure |
Nelfilcon A
n=32 Participants
Nelfilcon A contact lens
|
Narafilcon A
n=31 Participants
Narafilcon A contact lens
|
Total
n=63 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age Continuous
|
31.7 years
STANDARD_DEVIATION 8.4 • n=93 Participants
|
35.7 years
STANDARD_DEVIATION 11.9 • n=4 Participants
|
33.7 years
STANDARD_DEVIATION 10.4 • n=27 Participants
|
|
Sex: Female, Male
Female
|
17 Participants
n=93 Participants
|
24 Participants
n=4 Participants
|
41 Participants
n=27 Participants
|
|
Sex: Female, Male
Male
|
15 Participants
n=93 Participants
|
7 Participants
n=4 Participants
|
22 Participants
n=27 Participants
|
PRIMARY outcome
Timeframe: 4 weeks of wearPopulation: Per Protocol
Lens awareness, as interpreted by the subject and reported by the subject in a questionnaire as a single, retrospective evaluation of 4-week's wear time. Frequency of lens awareness was measured on a 4-point scale, with 1 being never and 4 being always. Four-week ratings were compared to baseline ratings, and a negative difference (4 week minus baseline) represented an improvement.
Outcome measures
| Measure |
Nelfilcon A
n=31 Participants
Nelfilcon A contact lens
|
Narafilcon A
n=30 Participants
Narafilcon A contact lens
|
|---|---|---|
|
Lens Awareness
|
8 Participants
|
9 Participants
|
Adverse Events
Nelfilcon A
Narafilcon A
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs
CIBA VISION
Results disclosure agreements
- Principal investigator is a sponsor employee For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
- Publication restrictions are in place
Restriction type: OTHER